Appointment Information
Practice Locations
Specialties
About Mina Nikanjam, MD, PhD
Mina Nikanjam, MD, is a medical oncologist who treats a wide variety solid tumors and hematologic malignancies. She has experience from academia and industry with designing and running clinical trials to bring state-of-the-art treatments to oncology patients. Many of these novel therapies are designed to be more effective with less toxicity and targeted for individualized therapy.
As an assistant professor in the Department of Medicine, Dr. Nikanjam instructs students, residents and fellows at UC San Diego. Her research interests include the use of computer modeling and simulation to determine how drug dose and blood levels relate to response to therapy (clinical pharmacology). She has co-authored numerous articles and her work has been published in journals such as The Oncologist, International Journal of Cancer, OncoImmunology, and Oncotarget, among others.
Dr. Nikanjam completed a fellowship in hematology-oncology at UCLA David Geffen School of Medicine and a residency in internal medicine at Kaiser Permanente Santa Clara. She earned her medical degree from UC San Diego School of Medicine and her doctoral degree from the UC Berkeley - UCSF Bioengineering Graduate Program. Dr. Nikanjam is board certified in internal medicine and medical oncology. She is a member of the American Society of Clinical Oncology and the American Society of Hematology.
Outside of work, Dr. Nikanjam enjoys running, playing beach volleyball, and spending time with her family.
UC San Diego Health Links
For more information see Cancer Care.
- Solid Tumors
- Hematologic Malignancies
Is My Insurance Accepted?
We accept most major insurance plans at UC San Diego Health. Find out if your insurance is accepted.
Open Payments Program Notification
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
View Open Payments Data for Dr. Nikanjam